Evidence map›Paper›PMID 36500816›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Development and Characterisation of a Whole Hybrid Sol-Gel Optofluidic Platform for Biosensing Applications.

Emma MacHugh, Graceson Antony, Arun Kumar Mallik, Alicja Kaworek, Declan McCormack, Brendan Duffy, Mohamed Oubaha

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma MacHughSchool of Chemical and Pharmaceutical Sciences, Technological University Dublin, City Campus Grangegorman, D07 H6K8 Dublin, Ireland.
Graceson AntonySchool of Physics and Clinical and Optometric Sciences, Technological University Dublin, City Campus Grangegorman, D07 H6K8 Dublin, Ireland.ORCID 0000-0002-7982-8390
Arun Kumar MallikPhotonics Research Centre, Technological University Dublin, City Campus Grangegorman, D07 H6K8 Dublin, Ireland.
Alicja KaworekCentre for Research in Engineering Surface Technology (CREST), FOCAS Institute, Technological University Dublin, 13 Camden Row, D02 HW71 Dublin, Ireland.
Declan McCormackSchool of Chemical and Pharmaceutical Sciences, Technological University Dublin, City Campus Grangegorman, D07 H6K8 Dublin, Ireland.
Brendan DuffyCentre for Research in Engineering Surface Technology (CREST), FOCAS Institute, Technological University Dublin, 13 Camden Row, D02 HW71 Dublin, Ireland.
Mohamed OubahaCentre for Research in Engineering Surface Technology (CREST), FOCAS Institute, Technological University Dublin, 13 Camden Row, D02 HW71 Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work outlines, for the first time, the fabrication of a whole hybrid sol-gel optofluidic platform by integrating a microfluidic biosensor platform with optical waveguides employing a standard photolithography process. To demonstrate the suitability of this new hybrid sol-gel optofluidic platform, optical and bio-sensing proof-of-concepts are proposed. A photoreactive hybrid sol-gel material composed of a photopolymerisable organically modified silicon alkoxide and a transition metal complex was prepared and used as the fabrication material for the entire optofluidic platform, including the optical waveguides, the sensing areas, and the microfluidic device. The most suitable sol-gel materials chosen for the fabrication of the cladding and core of the waveguides showed a RIC of 3.5 × 10

Indexed as

biosensingmicrofluidicoptical devicesorganic-inorganic sol-gel materialsphotolithographic fabricationwaveguides

Identifiers

PMID36500816
PMCPMC9740286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.